Recently, Akoumianakis et al. (2019) found that circulating WNT5A concentrations were significantly higher in patients with obesity, paralleled by decreased plasma levels of SFRP5. This evidence concerns the gene WNT5A and obesity due to melanocortin 4 receptor deficiency.